Omnicell Stock Cash And Equivalents
| OMCL Stock | USD 27.86 0.73 2.69% |
Omnicell fundamentals help investors to digest information that contributes to Omnicell's financial success or failures. It also enables traders to predict the movement of Omnicell Stock. The fundamental analysis module provides a way to measure Omnicell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omnicell stock.
Omnicell | Cash And Equivalents |
Omnicell Company Cash And Equivalents Analysis
Omnicell's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Omnicell Cash And Equivalents | 244.95 M |
Most of Omnicell's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omnicell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Omnicell Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Omnicell is extremely important. It helps to project a fair market value of Omnicell Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Omnicell's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Omnicell's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Omnicell's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
Omnicell Cash And Cash Equivalents Changes
Cash And Cash Equivalents Changes |
|
In accordance with the recently published financial statements, Omnicell has 244.95 M in Cash And Equivalents. This is 70.16% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 90.93% higher than that of the company.
Omnicell Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omnicell's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omnicell could also be used in its relative valuation, which is a method of valuing Omnicell by comparing valuation metrics of similar companies.Omnicell is currently under evaluation in cash and equivalents category among related companies.
Omnicell Fundamentals
| Return On Equity | -0.0176 | ||||
| Return On Asset | -0.0061 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 1.41 B | ||||
| Shares Outstanding | 45.92 M | ||||
| Shares Owned By Insiders | 1.40 % | ||||
| Shares Owned By Institutions | 98.60 % | ||||
| Number Of Shares Shorted | 2.37 M | ||||
| Price To Earning | 64.95 X | ||||
| Price To Book | 1.05 X | ||||
| Price To Sales | 1.09 X | ||||
| Revenue | 1.15 B | ||||
| Gross Profit | 596.71 M | ||||
| EBITDA | (34.87 M) | ||||
| Net Income | (20.37 M) | ||||
| Cash And Equivalents | 244.95 M | ||||
| Cash Per Share | 5.53 X | ||||
| Total Debt | 614.09 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.11 X | ||||
| Book Value Per Share | 26.11 X | ||||
| Cash Flow From Operations | 181.09 M | ||||
| Short Ratio | 4.78 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Price To Earnings To Growth | 2.28 X | ||||
| Target Price | 34.5 | ||||
| Number Of Employees | 3.65 K | ||||
| Beta | 0.76 | ||||
| Market Capitalization | 1.24 B | ||||
| Total Asset | 2.23 B | ||||
| Retained Earnings | 370.36 M | ||||
| Working Capital | 559.78 M | ||||
| Current Asset | 50.15 M | ||||
| Current Liabilities | 50.17 M | ||||
| Net Asset | 2.23 B |
About Omnicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omnicell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omnicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omnicell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Omnicell Investors Sentiment
The influence of Omnicell's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Omnicell. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Omnicell's public news can be used to forecast risks associated with an investment in Omnicell. The trend in average sentiment can be used to explain how an investor holding Omnicell can time the market purely based on public headlines and social activities around Omnicell. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Omnicell's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Omnicell's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Omnicell's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Omnicell.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Omnicell in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Omnicell's short interest history, or implied volatility extrapolated from Omnicell options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Omnicell Piotroski F Score and Omnicell Altman Z Score analysis. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.Note that the Omnicell information on this page should be used as a complementary analysis to other Omnicell's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Omnicell Stock analysis
When running Omnicell's price analysis, check to measure Omnicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnicell is operating at the current time. Most of Omnicell's value examination focuses on studying past and present price action to predict the probability of Omnicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnicell's price. Additionally, you may evaluate how the addition of Omnicell to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Omnicell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (0.45) | Revenue Per Share 25.372 | Quarterly Revenue Growth (0.13) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.